Upcoming Medical Conferences in BakersfieldSearch Criteria : United States of America Bakersfield
Rewire the Anxious Brain: Neuroscience-Informed Treatment of Anxiety, Panic and Worry is organized by PESI HealthCare and will be held on Sep 17, 2018 at Four Points by Sheraton Bakersfield, Bakersfield, California, United States of America. The target audience for this medical event is Social Workers, Psychologists, Counselors, Teachers, Occupational Therapists Marriage and Family Therapists, Case Managers, Addiction Counselors, Therapists, Nurses Other Mental Health Professionals. This CME Conference has been approved for a maximum of 6.25 clock hours of continuing education instruction. Course Description: Join Dr. Jamie Craig, licensed psychologist, and learn her keys for successful anxiety treatment. Dr. Craig integrates brain-based strategies for calming the anxious mind with client communication techniques that motivate change in your clients. Her approach promotes adherence to treatment and strengthens the therapeutic alliance - which is essential when working with anxious, worried, traumatized, or obsessive clients. Dr. Craig will give you tools and techniques to: • Identify and treat the roots of anxiety in both the amygdala and the cortex • Explain “the language of the amygdala” in an accessible, straightforward way • Identify how the cortex contributes to anxiety, and empower clients with strategies to resist anxiety-igniting cognitions Course Objectives: • Ascertain the underlying neurological processes that impact anxious symptoms for clients. • Develop client engagement in treatment using personalized goals and attending to the therapeutic relationship. • Evaluate the differences between amygdala-based and cortex-based anxiety symptoms and identify how these symptoms inform treatment interventions. • Communicate strategies for calming and training the amygdala in order to alleviate symptoms of anxiety. • Implement methods for teaching clients to retrain the cortex so that anxiety is resisted rather than exacerbated. • Analyze how psychotropic medication impacts neuroplasticity in the brain; identify related treatment implications.
Oct 13 - 14, 2018 | USD $500 | Pediatrics Neurology
Introduction to Neuro-Developmental Treatment (NDT) for Pediatrics is organized by Neuro-Developmental Treatment Association (NDTA) and will be held during Oct 13 - 14, 2018 at TERRIOKids, Bakersfield, California, United States of America. Course Description : This two-day course is designed for the therapist who treats or wants to treat pediatric clients (birth to 21 years) with neurological deficits. It is highly recommended for physical, occupational, and speech therapists and assistants and has a major focus on movement experiences in the lab. It includes the most current philosophy and principles of the Neuro-Developmental Treatment approach, comparison of atypical to typical development, assessing a client according to the ICF model, writing functional outcomes, and using task analysis to plan and sequence treatment strategies into an effective and efficient treatment session. Included are treatment videos and a demonstration to cement observational skills. Additional details will be posted as soon as they are available.
Psychopharmacology for Mental Health Professionals is organized by PESI HealthCare and will be held on Nov 02, 2018 at Four Points by Sheraton Bakersfield, Bakersfield, California, United States of America. Conference Description : Most clients with DSM-5 diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential. This seminar will update and increase your knowledge of : • Neurobiological underpinnings of major DSM-5 diagnoses • Effects and side effects of drugs used to treat these diagnoses • Responsibilities of the non-prescribing therapist to clients taking psychiatric medication Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this seminar is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5 disorders. You will leave this seminar with knowledge and confidence regarding effective and safe application of pharmacological drugs. Conference Objectives are : • Explain the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy. • Define the role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy. • Describe the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs. • Compare the effects and side effects of various psychotropic medications, including antipsychotics, antidepressants, benzodiazepines and anticonvulsants. • Discuss the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD. • Describe methods for prevention and early identification of prescription drug abuse among clients. Additional details will be posted as soon as they are available.